| scholarly article | Q13442814 |
| P50 | author | Brian L Egleston | Q64877076 |
| Mary B. Daly | Q96105692 | ||
| Roland Dunbrack | Q41050584 | ||
| P2093 | author name string | Yan Zhou | |
| Erica A Golemis | |||
| Michael J Hall | |||
| Veda N Giri | |||
| Eric A Ross | |||
| Emmanuelle Nicolas | |||
| Mark D Andrake | |||
| Dale L Bodian | |||
| Ilya G Serebriiskii | |||
| Joseph G Vockley | |||
| Sanjeevani Arora | |||
| Elizabeth D Handorf | |||
| P2860 | cites work | A candidate gene approach to searching for low-penetrance breast and prostate cancer genes | Q57306192 |
| PALB2 mutations in male breast cancer: a population-based study in Central Italy | Q57419720 | ||
| An Adenosine Triphosphatase of the Sucrose Nonfermenting 2 Family, Androgen Receptor-Interacting Protein 4, Is Essential for Mouse Embryonic Development and Cell Proliferation | Q57657799 | ||
| Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: Probability of synergistic effects | Q60289932 | ||
| Genetic/familial high-risk assessment: breast and ovarian, version 1.2014 | Q85253905 | ||
| Stratifying prostate patients for olaparib | Q87171153 | ||
| Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1 | Q24290549 | ||
| Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription | Q24299539 | ||
| The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates | Q24302254 | ||
| Structural basis for recruitment of BRCA2 by PALB2 | Q24315745 | ||
| PALB2 is an integral component of the BRCA complex required for homologous recombination repair | Q24316113 | ||
| Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer | Q24318553 | ||
| Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer | Q24616117 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| The SWISS-MODEL Repository and associated resources | Q24656047 | ||
| Transcriptional programs activated by exposure of human prostate cancer cells to androgen | Q24802648 | ||
| DNA double-strand break repair pathway choice and cancer | Q26996175 | ||
| PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies | Q27027503 | ||
| Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids | Q27641779 | ||
| Damaged DNA induced UV-damaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatinized DNA repair | Q27670880 | ||
| Aprataxin resolves adenylated RNA–DNA junctions to maintain genome integrity | Q27681030 | ||
| Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine | Q27853005 | ||
| Integrative clinical genomics of advanced prostate cancer | Q27853170 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice | Q28000121 | ||
| Development of human protein reference database as an initial platform for approaching systems biology in humans | Q28206967 | ||
| DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex | Q28213052 | ||
| Germline mutations in HOXB13 and prostate-cancer risk | Q28257179 | ||
| Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4 | Q28510482 | ||
| BioAssemblyModeler (BAM): user-friendly homology modeling of protein homo- and heterooligomers | Q28658281 | ||
| SIFT: Predicting amino acid changes that affect protein function | Q29547211 | ||
| The mutational landscape of lethal castration-resistant prostate cancer | Q29614634 | ||
| A systematic survey of loss-of-function variants in human protein-coding genes | Q29615756 | ||
| Non-manifesting AHI1 truncations indicate localized loss-of-function tolerance in a severe Mendelian disease gene | Q30009241 | ||
| PAPSS2 deficiency causes androgen excess via impaired DHEA sulfation--in vitro and in vivo studies in a family harboring two novel PAPSS2 mutations | Q30408472 | ||
| Human DNA repair genes | Q31963889 | ||
| Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis | Q33864038 | ||
| Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. | Q33962627 | ||
| Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene | Q33981506 | ||
| Identification of a protein essential for a major pathway used by human cells to avoid UV- induced DNA damage | Q34048520 | ||
| An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis | Q34071472 | ||
| Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer | Q34252397 | ||
| Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism | Q34382405 | ||
| Double-strand break repair: 53BP1 comes into focus | Q34391068 | ||
| Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer | Q34461177 | ||
| Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. | Q34713545 | ||
| Common variation in the BRCA1 gene and prostate cancer risk. | Q34857410 | ||
| Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian | Q34945185 | ||
| SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins | Q35032489 | ||
| Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing | Q35146870 | ||
| DNA damage and breast cancer | Q35201664 | ||
| Predicting the functional impact of protein mutations: application to cancer genomics | Q35224321 | ||
| Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction | Q35538234 | ||
| Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk | Q35682864 | ||
| Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations | Q35689810 | ||
| Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations | Q35854930 | ||
| Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) | Q35868793 | ||
| PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels | Q35927145 | ||
| Role of transcriptional corepressor CtBP1 in prostate cancer progression | Q36343763 | ||
| Non-Bloom syndrome-associated partial and total loss-of-function variants of BLM helicase | Q36436735 | ||
| Receptor-interacting protein 140 is a repressor of the androgen receptor activity | Q36464850 | ||
| HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). | Q36503369 | ||
| DNA interstrand crosslink repair and cancer | Q36576047 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer | Q36805426 | ||
| Genome-wide association analysis identifies three new breast cancer susceptibility loci | Q36842233 | ||
| DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. | Q37247163 | ||
| Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group. | Q37384036 | ||
| Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease | Q37650650 | ||
| 53BP1, BRCA1, and the choice between recombination and end joining at DNA double-strand breaks | Q37713592 | ||
| Integrated network analyses for functional genomic studies in cancer | Q38118021 | ||
| The genetic epidemiology of prostate cancer and its clinical implications | Q38168060 | ||
| When and how to perform genetic testing for inherited colorectal cancer syndromes | Q38171078 | ||
| Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. | Q38215563 | ||
| Genetic predisposition to prostate cancer: Update and future perspectives | Q38226480 | ||
| Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice. | Q38306993 | ||
| Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment. | Q38345083 | ||
| Altered glycosylation in prostate cancer | Q38366334 | ||
| From candidate gene studies to GWAS and post-GWAS analyses in breast cancer | Q38366358 | ||
| Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, | Q38370247 | ||
| New target genes in endometrial tumors show a role for the estrogen-receptor pathway in microsatellite-unstable cancers. | Q38955474 | ||
| Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses | Q38981181 | ||
| FANCJ localization by mismatch repair is vital to maintain genomic integrity after UV irradiation | Q39042130 | ||
| Androgen receptor signaling regulates DNA repair in prostate cancers | Q39096880 | ||
| A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells | Q39195814 | ||
| DDB2 is a novel AR interacting protein and mediates AR ubiquitination/degradation | Q39305637 | ||
| Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi Anemia pathway | Q39462876 | ||
| Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature | Q40255561 | ||
| Hereditary prostate cancer: epidemiologic and clinical features | Q40831820 | ||
| A polygenic model of inherited predisposition to cancer. | Q40938884 | ||
| Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population. | Q41133980 | ||
| Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations | Q41833215 | ||
| The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness | Q42035769 | ||
| Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members | Q43726748 | ||
| Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic stress | Q45309004 | ||
| Molecular and in silico analysis of BRCA1 and BRCA2 variants | Q45377566 | ||
| A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. | Q46000370 | ||
| MutationTaster2: mutation prediction for the deep-sequencing age. | Q52877992 | ||
| Association between mismatch repair gene MSH3 codons 1036 and 222 polymorphisms and sporadic prostate cancer in the Iranian population. | Q54331839 | ||
| Chek2 DNA damage response pathway and inherited breast cancer risk. | Q54564800 | ||
| Colorectal cancer and polymorphisms in DNA repair genes WRN , RMI1 and BLM | Q57192142 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | familial prostate cancer | Q56014587 |
| P304 | page(s) | 39614-39633 | |
| P577 | publication date | 2015-10-14 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer | |
| P478 | volume | 6 |
| Q91965108 | A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer |
| Q92015319 | A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer |
| Q92608513 | Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors |
| Q38685097 | Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods |
| Q56475873 | Molecular mechanisms of the preventable causes of cancer in the United States |
Search more.